mianserin has been researched along with Anochlesia in 7 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Co-treatment with risperidone and escitalopram (5mg/kg) or mirtazapine (10mg/kg) more efficiently increased the release of 5-HT but not DA in the rat frontal cortex, as compared to drugs given alone." | 1.48 | The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex. ( Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A, 2018) |
| "Rats treated with haloperidol at doses of 0." | 1.37 | Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats. ( Haleem, DJ; Shireen, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamińska, K | 1 |
| Górska, A | 1 |
| Noworyta-Sokołowska, K | 1 |
| Wojtas, A | 1 |
| Rogóż, Z | 1 |
| Gołembiowska, K | 1 |
| Shireen, E | 1 |
| Haleem, DJ | 1 |
| Subarnas, A | 1 |
| Tadano, T | 1 |
| Oshima, Y | 1 |
| Kisara, K | 1 |
| Ohizumi, Y | 1 |
| Berendsen, HH | 1 |
| Broekkamp, CL | 1 |
| Pinder, RM | 1 |
| Leitch, IM | 1 |
| Rawlow, A | 1 |
| Rechtman, MP | 1 |
| Yamada, K | 1 |
| Furukawa, T | 1 |
| Al-Khatib, IM | 1 |
| Fujiwara, M | 1 |
| Ueki, S | 1 |
7 other studies available for mianserin and Anochlesia
| Article | Year |
|---|---|
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locom | 2018 |
Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats.
Topics: Animals; Antipsychotic Agents; Catalepsy; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Ha | 2011 |
Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
Topics: Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Catalepsy; Central Nervous System; Dose | 1993 |
Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Ag | 1998 |
Pharmacological evaluation of two novel analogues of mianserin: 2-N-carboxamidinonormianserin (FCC5) and 2-N-carboxamidonormianserin (FCC13).
Topics: Animals; Blood Pressure; Bronchoconstriction; Catalepsy; Central Nervous System; Decerebrate State; | 1992 |
[Behavioral effects of a new antidepressant, setiptiline].
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dru | 1991 |
Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
Topics: Animals; Antidepressive Agents; Catalepsy; Dopamine; Haloperidol; Imipramine; Male; Methamphetamine; | 1989 |